Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: We developed interpretable machine learning(ML) models to predict overall survival in bladder cancer patients. This approach aims to improve the interpretability and transparency of our modeling results. METHODS: We collected clinical and pathological information on bladder cancer patients from the SEER database, allocating it to training and validation sets in a 7:3 ratio. At the same ...
OBJECTIVE: Tumor budding (TB) is a histopathological marker of aggressive behavior and poor prognosis in rectal cancer (RC), yet not reliably evaluated preoperatively. We assessed whether histogram features from amide proton transfer-weighted (APTw) imaging and apparent diffusion coefficient (ADC) maps could serve as noninvasive biomarkers for preoperative TB grade prediction. MATERIALS AND METHOD...
G protein-coupled receptors (GPCRs) serve as central hubs in tumor signal transduction and microenvironment regulation. However, their therapeutic exp...
PURPOSE: To evaluate the segmentation performance and total metabolic tumor volume (TMTV) prediction accuracy of 2D and 3D nnU-Net models under two-la...
OBJECTIVES: Identifying patients at risk of chemoresistant osteosarcoma enables risk-adapted management. This study aimed to predict chemoresistant os...
BACKGROUND: Large language models (LLMs), a form of generative artificial intelligence (AI), are increasingly explored for clinical applications due t...
Accurate grading of brain tumors from multiparametric MRI is a critical step in treatment planning, yet deep learning models trained for this task rem...
BACKGROUND: Explainable artificial intelligence (xAI) is increasingly used in medical imaging to enhance transparency, clinical interpretability, and ...
Treatment planning is a multi-disciplinary effort that requires medical decision-making, specialized training, and access to specialized software. Rec...
OBJECTIVE: We aimed to propose a prognostic framework using a dual-branch Vision Transformer (ViT) deep learning (DL) architecture for stratifying rec...
E3 ubiquitin ligases recognize substrates through specific interfaces. Accurate delineation of these interfaces is essential, as mutations disrupting ...
Breast cancer's genomic heterogeneity complicates drug discovery, making repurposing an attractive but challenging strategy. Advances in artificial in...
Esophageal cancer is a highly aggressive malignancy where early detection is critical for survival. However, early-stage lesions typically present sub...
Predicting biological responses to ionizing radiation is challenging due to the complex, multi-scale mechanisms involved. Traditional machine learning...
Biomarker research for cancer diagnosis and prognosis has rapidly expanded technologically and thematically, along with advancements in molecular diag...
Heart failure (HF) and malignancy represent two major global health burdens that frequently coexist and lead to poor clinical outcomes. However, the s...
Prediction of patient-level drug response is critical for precision oncology but remains limited by the scarcity of clinical data. While machine learn...
Artificial intelligence is transforming drug discovery by enabling exploration of vast chemical spaces and the design of new molecules with tailored p...
OBJECTIVES: This study evaluates the clinical utility of an artificial intelligence (AI)-driven volumetric approach for assessing treatment response i...
Multi-omics is the coordinated acquisition, integration, and interpretation of multiple datasets generated from diverse molecular layers of a biologic...